NCT02135757View on ClinicalTrials.gov

Study to Evaluate Real-world Pharmacoeconomics and Resistance Mechanisms of Panitumumab in Metastatic Colorectal Cancer Patients

CompletedOBSERVATIONAL
Enrollment

23

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

March 31, 2018

Study Completion Date

March 31, 2018

Conditions
Colorectal Cancer Metastatic
Trial Locations (2)

J4V 2H1

Hôpital Charles-Le Moyne, Greenfield Park

H3T 1E2

Jewish General Hospital, Montreal

Sponsors

Lead Sponsor

PeriPharm
All Listed Sponsors
collaborator

Personalized Medicine Partnership for Cancer

OTHER

lead

PeriPharm

OTHER

NCT02135757 - Study to Evaluate Real-world Pharmacoeconomics and Resistance Mechanisms of Panitumumab in Metastatic Colorectal Cancer Patients | Biotech Hunter | Biotech Hunter